Premium
Increased S‐100 protein‐immunoreactivity of Kupffer cells is associated with lymphohematological malignancy
Author(s) -
Niki Toshiro,
Oka Teruaki,
Shiga Junji,
Takahashi Kiyoshi,
Geerts Albert,
Machinami Rikuo
Publication year - 1995
Publication title -
pathology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
eISSN - 1440-1827
pISSN - 1320-5463
DOI - 10.1111/j.1440-1827.1995.tb03391.x
Subject(s) - malignancy , pathology , kupffer cell , immunohistochemistry , autopsy , lymphoma , medicine , leukemia , biology , immunology
The distribution of S‐100 protein in normal tissue has been studied extensively. However, little is known about its expression in pathologic states. The aim of the present study was to investigate the expression of S100 protein in diseased human liver, especially in Kupffer cells. One hundred cases of autopsy livers originating from patients with various diseases were examined. Increased S‐100‐immunoreactivity of Kupffer cells was observed in six cases. Of the six cases, four were derived from a lymphohematologic malignancy, such as B cell lymphoma, B cell lymphoblastic leukemia, muitiple myeloma and chronic myelogenous leukemia with lymphoblastic crisis. Lymphohematologic malignancy accounted for 16 out of the 100 cases examined. Thus, increased S‐100‐positive Kupffer cells was significantly associated with lymphohematologic malignancy (P<0.01); 25% (4/16) in cases with lymphohematologic malignancy versus 2.4% (2/84) in the remaining cases. Moreover, some of these S‐100‐positive Kupffer cells were positive for S‐100 β‐subunit, which is not normally expressed by Kupffer cells. Although the reason for this increased S‐100‐immunoreactivity is speculative, the authors' hypothesis is that tumor cells may produce some factor(s) that induce the expression of S‐100 protein in Kupffer cells.